Tocilizumab in Systemic Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tocilizumab in Systemic Sclerosis: A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial
Lancet Respir Med 2020 Aug 28;[EPub Ahead of Print], D Khanna, CJF Lin, DE Furst, J Goldin, G Kim, M Kuwana, Y Allanore, M Matucci-Cerinic, O Distler, Y Shima, JM van Laar, H Spotswood, B Wagner, J Siegel, A Jahreis, CP Denton,From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.